Group 1 - Investors have taken a bullish stance on Eli Lilly, with significant options trades indicating potential upcoming movements [1][2] - The overall sentiment among large traders is 61% bullish and 23% bearish, with a total of 26 uncommon options trades identified [2] - The targeted price range for Eli Lilly over the last three months is between $920.0 and $1220.0 [3] Group 2 - The mean open interest for Eli Lilly options trades is 381.0, with a total volume of 3,731.00 [4] - Eli Lilly is a pharmaceutical company focusing on neuroscience, cardiometabolic, cancer, and immunology, with key products including Verzenio, Mounjaro, and Taltz [5] - Recent analyst ratings suggest an average target price of $1289.6 for Eli Lilly [7] Group 3 - Eli Lilly's current trading volume is 613,828, with a price increase of 3.16%, now at $1041.46 [8]
Eli Lilly Unusual Options Activity For February 23 - Eli Lilly (NYSE:LLY)